The recent announcement that CVS Caremark will use value-based metrics to inform formulary design at first appears a step in the right direction. However, using value measurements from a single nongovernmental organization—the Institute for Clinical and Economic Review (ICER)—based on a limited picture of treatment value may be problematic. Using this single assessment of value in an effort solely to exclude drugs from a major insurance formulary is even more worrisome and fails to recognize the […]
Challenges persist in measuring value in healthcare, and individual healthcare decision makers need personalized information about value to make informed choices. Precision’s Mark Linthicum, Jennifer Bright, and Jason Shafrin explore an open-source modeling approach to value assessment in an article for Journal of Clinical Pathways.
We sat down with PHE Chief Scientific Officer Darius Lakdawalla to discuss novel sources of value, value assessments, and his upcoming ISPOR issue panel addressing state-of-the-art approaches to conducting decision analysis in healthcare.
For more information, or to learn how to change your cookies preferences, please click here.